CAURS - Overview: Candida auris Surveillance, Molecular Detection, PCR, Varies
Detecting Candida auris from surveillance swabs This test should not be used to determine cure or to monitor response to therapy.
CDU - Overview: Cadmium, 24 Hour, Urine
Detecting exposure to cadmium, a toxic heavy metal, in 24-hour urine specimens
F_2 - Overview: Coagulation Factor II Activity Assay, Plasma
Diagnosing a congenital deficiency (rare) of coagulation factor II Evaluating acquired deficiencies associated with liver disease or vitamin K deficiency, oral anticoagulant therapy, and antibody-induced deficiencies (eg, in association...
CALU - Overview: Calcium, 24 Hour, Urine
Evaluation of calcium oxalate and calcium phosphate kidney stone risk, and calculation of urinary supersaturation Evaluation of bone diseases, including osteoporosis and osteomalacia
CD20I - Overview: CD20 Immunostain, Technical Component Only
Classification of lymphomas
GRH - Overview: Growth Hormone Immunostain, Technical Component Only
Aids in the identification of growth hormone adenomas
MAGU - Overview: Magnesium, 24 Hour, Urine
Assessing the cause of abnormal serum magnesium concentrations using a 24-hour urine collection Determining whether nutritional magnesium loads are adequate Calculating urinary calcium oxalate and calcium phosphate supersaturation and...
MNU - Overview: Manganese, 24 Hour, Urine
Monitoring manganese exposure using 24 hour urine collections Nutritional monitoring
MYOGL - Overview: Myoglobin Immunostain, Technical Component Only
Marker of skeletal and cardiac muscle
C5B9 - Overview: SC5b-9 Level Terminal Complement Complex, Plasma
Detecting increased complement activation
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.